Researchers from the OLLA-MED LLC center took part in the national congress dedicated to the diagnosis and treatment of respiratory diseases. During the congress, colleagues exchanged experience on a wide range of interdisciplinary problems and outlined ways for further cooperation.
Recruitment of patients who have had pulmonary tuberculosis into a clinical trial of the GamTBVac vaccine has begun to evaluate the effectiveness of the vaccine in preventing relapse. Remuneration for participation in the study is possible. Write to us 8 (993) 202 7840 (whatsapp).
Our site will conduct a study of a new medicine for the treatment of bronchial asthma. The study will begin in November 2023, we invite patients for pre-selection!
The selection visit for the study of a new genetically engineered medicine in patients with adult Still's disease was successfully completed. We invite patients for pre-selection!
